The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and the related notes that appear elsewhere in this document.



The information in this Quarterly Report on Form 10-Q contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as
amended ("Securities Act"), and Section 21E of the Securities Exchange Act of
1934, as amended ("Exchange Act"), which are subject to the "safe harbor"
created by those sections. These forward-looking statements reflect our
management's beliefs and views with respect to future events and are based on
estimates and assumptions as of the date of this report and are subject to risks
and uncertainties. We may, in some cases, use words such as "anticipate,"
"believe," "could," "continue," "estimate," "expect," "intend," "may,"
"objective," "plan," "potential," "predict," "project," "should," "will,"
"would," or the negative of those terms, and similar expressions that convey
uncertainty of future events or outcomes to identify these forward-looking
statements. Forward-looking statements in this report include, but are not
limited to, statements regarding:

• our plans to focus on oscillators, clock ICs, resonators and timing

synchronization solutions and to aggressively expand our presence in these

markets;

• the impact of the COVID-19 pandemic on our business, employees, revenue and

other operating results, liquidity, and cash flows, and its impact on the

businesses of our suppliers and customers, and our anticipated responses

thereto;

• our ability to address market and customer demands and to timely develop new

or enhanced solutions to meet those demands;

• anticipated trends, challenges and growth in our business and the markets in

which we operate, including pricing expectations;

• our expectations regarding our revenue, gross margin, and expenses;

• expected impact of new legislation and IRS guidance issued in response to the

COVID-19 pandemic;

• our belief as to the sufficiency of our existing cash and cash equivalents and

funds available for borrowing under our credit facilities to meet our cash

needs for at least the next 12 months and our future capital requirements over

the longer term, including the potential impact of the COVID-19 pandemic

thereon;

• our expectations regarding dependence on our largest customer;

• our customer relationships and our ability to retain and expand our customer

relationships and to achieve design wins;

• the success, cost, and timing of new products;

• the size and growth potential of the markets for our solutions, and our

ability to serve and expand our presence in those markets;

• our plans to expand sales and marketing efforts through increased

collaboration with our distributors, resellers, and contracted sales

representatives, and our plans to introduce a self-service web portal as well

as digital marketing campaigns for branding and lead generation;

• our goal to become the leading timing solution provider for advanced and

challenging applications;

• our positioning of being designed into current systems as well as future

products;

• our belief that our advanced packaging designs can enable the smallest

footprints in the industry;

• our expectations regarding competition in our existing and future markets;

• regulatory developments in the United States and foreign countries;

• the performance of, and our relationships with, our third-party suppliers and

manufacturers;

• our and our customers' ability to respond successfully to technological or

industry developments;

• our ability to attract and retain key personnel;

• intellectual property and related litigation;

• the adequacy and availability of our leased facilities;

• the accuracy of our estimates regarding capital requirements, expectations

regarding renewal of loans, and needs for additional financing.




In addition, any statements contained herein that are not statements of
historical facts may be deemed to be forward-looking statements. Forward­looking
statements are subject to a number of risks and uncertainties that could cause
actual results to differ materially from those expected or referenced in these
forward-looking statements. These risks and uncertainties include, but are not
limited to, those risks discussed in Part II, Item 1A Risk Factors of this
report. Moreover, we operate in a very competitive and rapidly changing
environment. New risks emerge from time to time. It is not possible for our
management to predict all risks, nor can we assess the impact of all factors on
our business or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in any
forward-looking statements we may make. Given these uncertainties, you should
not place undue reliance on these forward-looking statements. We qualify all of
the forward-looking statements in this report by these cautionary statements.

You should not rely upon forward-looking statements as predictions of future
events. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee that the future
results, levels of activity, performance, or events and circumstances reflected
in the forward-looking statements will be achieved or occur. Moreover, neither
we nor any other



                                       16

--------------------------------------------------------------------------------


person assumes responsibility for the accuracy and completeness of the
forward-looking statements. We undertake no obligation to update publicly any
forward looking statements for any reason after the date of this report to
conform these statements to actual results or to changes in our expectations,
except as required by law.

Overview

We are a leading provider of silicon timing solutions. Our timing solutions are
the heartbeat of our customers' electronic systems, solve complex timing
problems and enable industry-leading products. We provide solutions that are
differentiated by high performance and reliability, programmability, small size,
and low power consumption. Our products have been designed into over 250
applications across our target markets, including communications and enterprise,
automotive, industrial, aerospace, and mobile, IoT and consumer.

We commenced commercial shipments of our first oscillator products in 2006. Substantially all of our revenue to date has been derived from sales of oscillator systems across our target end markets. We intend to focus on clock IC and timing sync solutions in the future. We seek to aggressively expand our presence in these two markets.



We sell our products primarily through distributors and resellers, who in turn
sell to our end customers. We also sell products directly to end customers who
integrate our products into their applications. Based on sell-through
information provided by these distributors, we believe the majority of our end
customers are based in the U.S.

We operate a fabless business model, allowing us to focus on the design, sales,
and marketing of our products, quickly scale production, and significantly
reduce our capital expenditures. We leverage our global network of distributors
and resellers to address the broad set of end markets we serve. For our largest
accounts, dedicated sales personnel work with the end customer to ensure that
our solutions fully address the end customer's timing needs. Our smaller
customers work directly with our distributors to select the optimum timing
solution for their needs.

We were acquired by MegaChips in 2014 and were a wholly-owned subsidiary of
MegaChips, a fabless semiconductor company based in Japan and traded on the
Tokyo Stock Exchange, until November 25, 2019. On November 25, 2019, we
completed the initial public offering of shares of our common stock. On June 16,
2020, we completed a follow-on public offering, in which we issued and sold
1,525,000 shares of our common stock and MegaChips sold 2,500,000 shares of our
common stock held by them. On February 22, 2021, we completed an additional
follow-on public offering, in which we issued and sold 1,500,000 shares of our
common stock and MegaChips sold 1,500,000 shares of our common stock held by
them. MegaChips continues to be our largest stockholder and held approximately
31.5% of our common stock as of June 30, 2021.

We are currently experiencing a growth in demand for some of our products,
however, there are a number of industry-wide supply constraints affecting the
supply of analog circuits manufactured by certain foundries, including Taiwan
Semiconductor Manufacturing Company, which may limit our ability to fully
satisfy the increase in demand. If we cannot ship our products to our customers
on time and in the quantity required as a result of this supply constraint our
sales could decline and we could lose customers.

Impact of COVID-19 on our Business



The future impact of the ongoing COVID-19 pandemic on our business remains
unknown. In an effort to protect the health and safety of our employees, we took
proactive actions and adopted social distancing policies at our locations around
the world, including requiring employees to work from home ("WFH") in certain
locations, reducing the number of people in certain of our sites at any one
time, and limiting employee travel. In an effort to contain the COVID-19
pandemic or slow its spread, governments around the world have also enacted
various measures, including orders to close all businesses not deemed
"essential," isolate residents in their homes or places of residence, and
practice social distancing. In addition, the United States and other countries
in which we operate have imposed measures such as quarantines and
"shelter-in-place" orders that restrict business operations and travel and
require individuals to WFH, which has impacted all aspects of our business, as
well as those of the third-parties we rely upon for our manufacturing, assembly,
testing, shipping and other operations. The current and future spread of
COVID-19 variants may cause the reinstatement of one or more of these measures.



                                       17

--------------------------------------------------------------------------------


We anticipate the global health crisis caused by the COVID-19 pandemic will
continue to impact business activity across the globe and will continue to
impact our business, employees and operations for the foreseeable future. We
believe that the COVID-19 pandemic could cause delay and disruption in the
manufacture, shipment, and sales of, and overall demand for, our products. In
addition, we believe the production capabilities of our suppliers has been, and
may continue to be, impacted as a result of quarantines, closures of production
facilities, lack of supplies, or delays caused by restrictions on travel or WFH
orders. For example, in March 2020, the government of Malaysia announced
measures to restrict movement in that country to suppress the number of COVID-19
cases, which have been extended currently until August 2021. These restrictions
could limit our suppliers' ability to operate their manufacturing facilities in
that country. Any delay or disruption in the manufacture, shipment and sales of,
or overall demand for, our products in turn may negatively and materially impact
our operating and financial results, including revenue, gross margins, operating
margins, cash flows and other operating results. Further, the resumption of
normal business operations after such disruptions may be delayed and a
resurgence of COVID-19 could result in continued disruption to us, our
suppliers, and/or our customers. To date, we have experienced minimal impact
from any supplier disruption. The duration and full magnitude of the COVID-19
pandemic's impact on credit and financial markets is also unknown, which creates
uncertainty as to the financial condition of our distributors or customers. In
addition, the deterioration in credit markets could limit our ability to obtain
external financing to fund our operations and capital expenditures. We may also
experience losses on our holdings of cash and investments due to failures of
financial institutions and other parties.

We currently have employees, third-party contractors, distributors, and
customers in numerous countries throughout the world that have each been
impacted by the COVID-19 pandemic. The COVID-19 pandemic has restricted and is
expected to continue to restrict travel and use of our facilities and the
facilities of our suppliers, customers, or other vendors in our supply chain,
which could impact our business, interactions and relationships with our
customers, third-party suppliers and contractors, and results of operations. We
cannot predict with certainty what other impacts the COVID-19 pandemic may have
on our business, employees, service providers, customers and results of
operations.

There remains a high degree of uncertainty in the global business environment
given the impact of the COVID-19 pandemic which creates challenges with
visibility beyond the near term. We will continue to actively monitor the
situation and may take further actions altering our business operations that we
determine are in the best interests of our employees, customers, partners,
suppliers, and stakeholders, or as required by federal, state, or local
authorities. It is not clear what the potential effects any such alterations or
modifications may have on our business, including the effects on our customers,
employees, operations, and prospects, or on our financial results for remainder
of fiscal 2021 or beyond.  For additional discussion, please see Part II, Item
1A Risk Factors of this report.

Results of Operations

Revenue



We derive revenue primarily from sales of silicon timing products to
distributors and resellers who in turn sell to our end customers. We also sell
products directly to end customers who integrate our products into their
applications. Our sales are made pursuant to standard purchase orders which may
be cancelled, reduced, or rescheduled, with little or no notice. We recognize
product revenue upon shipment when we satisfy our performance obligations as
evidenced by the transfer of control of our products to customers. We measure
revenue based on the amount of consideration we expect to be entitled to in
exchange for products.



                        Three Months Ended June 30,               Change               Six Months Ended June 30,               Change
                         2021                 2020             $           %           2021                2020             $           %
                                                               (in thousands except percentage)
Revenue             $       44,496       $       21,473     $ 23,023       107 %   $      80,038       $      43,215     $ 36,823        85 %




Revenue increased by $23.0 million, or 107% , for the three months ended
June 30, 2021 compared to the same period in the prior year. The increase was
primarily related to 66% higher volume of shipments year over year and an
increase of 25% in average selling price ("ASPs") of our products. The increase
in sales volume was driven by higher demand for our products from new and
existing customers, including new design wins at new and existing customers. The
ASP increase was related to change in mix of the products we shipped and
increase in selling prices for certain customers.



Revenue increased by $36.8 million, or 85%, for the six months ended June 30,
2021 compared to the same period in the prior year. The increase was primarily
related to 53% higher volume of shipments year over year and an increase of 21%
in ASPs. The increase in sales volume was driven by higher demand for our
products from new and existing customers, including new design wins at new and
existing customers. The ASP increase was related to change in mix of the
products we shipped and increase in selling prices for certain customers.





                                       18

--------------------------------------------------------------------------------




We expect our revenue to fluctuate in the future primarily based on the volume
of shipments and ASP changes. We may not be able to sustain our ASP increases in
the future at this current rate.



For the three and six months ended June 30, 2021 and 2020, sales attributable to
our largest end customer accounted for 15%, 25%, 26%, and 30%, respectively, of
our revenue. Our end customers predominantly purchase our products from
distributors. For the three and six months ended June 30, 2021 and 2020, our top
three distributors by revenue together accounted for approximately 46%, 53%,
51%, and 54%, respectively, of our revenue. Revenue attributable to our largest
ten end customers accounted for 47%, 51%, 50% and 51%, respectively, of our
revenue for the three and six months ended June 30, 2021 and 2020.

Cost of Revenue, Gross Profit, and Gross Margin



Cost of revenue consists of wafers acquired from third-party foundries,
assembly, packaging, and test cost of our products paid to third-party contract
manufacturers, and personnel and other costs associated with our manufacturing
operations. Cost of revenue also includes depreciation of production equipment,
inventory write-downs, amortization of internally developed software, shipping
and handling costs, and allocation of overhead and facility costs. We also
include credits for rebates received from foundries to cost of revenue.



                        Three Months Ended June 30,               Change               Six Months Ended June 30,               Change
                         2021                 2020             $           %           2021                2020             $           %
                                 (in thousands except percentage)                              (in thousands except percentage)

Cost of Revenue     $       17,669       $       11,490     $  6,179        54 %   $      34,393       $      23,256     $ 11,137        48 %
Gross Profit                26,827                9,983       16,844       169 %          45,645              19,959       25,686       129 %
Gross Margin                    60 %                 46 %                                     57 %                46 %




Gross profit increased by $16.8 million in the three months ended June 30, 2021
compared to the same period in the prior year. Gross profit increased a net
$18.4 million mainly from higher sales volume and an increase in ASPs of our
products. This increase was offset by higher other manufacturing and overhead
costs of $1.6 million of which $0.4 million was related to higher stock-based
compensation expense.



Gross profit increased by $25.7 million in the six months ended June 30, 2021
compared to the same period in the prior year. Gross profit increased a net
$28.2 million mainly from higher sales volume and an increase in ASPs of our
products. This increase was offset by higher other manufacturing and overhead
costs of $2.5 million of which $0.8 million was related to higher stock-based
compensation expense.



Gross margin was higher by 14% in the three months ended June 30, 2021 when
compared to the same period in the prior year. The gross margin increased by 10%
from higher sales volume and an increase in ASPs. There was additonal 4%
improvement in our other manufacturing costs as it decreased as a percentage of
revenue.



Gross margin was higher by 11% in the six months ended June 30, 2021 when
compared to the same period in the prior year. The gross margin increased by 8%
from higher sales volume and an increase in ASPs. There was additonal 3%
improvement in our other manufacturing costs as it decreased as a percentage of
revenue.



Operating Expenses

Our operating expenses consist of research and development, sales and marketing, and general and administrative expenses. Personnel costs are the most significant component of our operating expenses and consist of salaries, benefits, bonuses, stock-based compensation, and commissions. Our operating expenses also include consulting costs, allocated costs of facilities, information technology and depreciation.





                        Three Months Ended June 30,              Change              Six Months Ended June 30,               Change
                         2021                 2020             $         %           2021                2020             $           %
                                (in thousands except percentage)                             (in thousands except percentage)

Operating
Expenses:
Research and
development         $       12,067       $        7,398     $ 4,669       63 %   $      23,247       $      14,422     $  8,825        61 %
Selling, general
and
administrative              12,686                7,856       4,830       61 %          23,809              15,664        8,145        52 %
Total operating
expenses            $       24,753       $       15,254     $ 9,499       62 %   $      47,056       $      30,086     $ 16,970        56 %






                                       19

--------------------------------------------------------------------------------





Research and Development

Our research and development efforts are focused on the design and development
of next-generation silicon timing systems solutions. Our research and
development expense consists primarily of personnel costs, which include
stock-based compensation, pre-production engineering mask costs, software
license and intellectual property expenses, design tools and prototype-related
expenses, facility costs, supplies, professional and consulting fees, and
allocated overhead costs. We expense research and development costs as
incurred. We believe that continued investment in our products and services is
important for our future growth and acquisition of new customers and, as a
result, we expect our research and development expenses to continue to increase
in absolute dollars. However, we expect our research and development expense to
fluctuate as a percentage of revenue from period to period depending on the
timing of these expenses.



Research and development expense increased by $4.7 million, or 63%, for the
three months ended June 30, 2021 compared to the same period in the prior year,
primarily due to higher personnel costs of $1.9 million due to increased
headcount, an increase in stock-based compensation expense of $1.8 million, and
higher project expenses.



Research and development expense increased by $8.8 million, or 61%, for the six
months ended June 30, 2021 compared to the same period in the prior year,
primarily due to an increase in stock-based compensation expense of $3.6
million, higher personnel costs of $3.1 million due to increased headcount, and
higher project expenses.

Sales, General and Administrative



Sales, general and administrative expense consists of personnel costs, including
stock-based compensation, professional and consulting fees, accounting and audit
fees, legal costs, field application engineering support, travel costs,
advertising expenses and allocated overhead costs. We expect sales, general and
administrative expense to continue to increase in absolute dollars as we
increase our personnel and grow our operations, although it may fluctuate as a
percentage of revenue from period to period depending on the timing of these
expenses.

Selling, general and administrative expense increased by $4.8 million, or 61%,
for the three months ended June 30, 2021 compared to the same period in the
prior year, primarily due to higher personnel costs of $1.9 million related to
increased headcount and commissions and higher stock-based compensation expense
of $1.9 million.

Selling, general and administrative expense increased by $8.1 million, or 52%,
for the six months ended June 30, 2021 compared to the same period in the prior
year, primarily due to higher stock-based compensation expense of $3.9 million,
higher personnel costs of $2.1 million largely related to increased headcount
and higher commission expenses of $1.5 million due to increased revenue.

Other Expense (Income)



Other expense (income) consists primarily of interest expense on our outstanding
debt, interest income on our cash balances, foreign exchange gains and losses,
and asset dispositions. See Note 9 to our condensed consolidated financial
statements under Item 1 for more information about our debt.



                       Three Months Ended June 30,             Change                Six Months Ended June 30,              Change
                       2021                 2020            $          %            2021                 2020            $          %
                               (in thousands except percentage)                             (in thousands except percentage)

Interest Expense    $         -         $         313     $ (313 )     (100 %)   $         -         $         616     $ (616 )     (100 %)
Other expense
(income), net                28                    20          8         40 %             68                   (48 )      116       (242 %)
Total other
expense             $        28         $         333     $ (305 )      (92 %)   $        68         $         568     $ (500 )      (88 %)




Other expense decreased $0.3 million and $0.5 million for three and six months
ended June 30, 2021 compared to the same period in the prior year, primarily as
a result of interest expense savings from paying down of all our outstanding
loans under our credit facilities.

Income Tax Expense



Income tax expense consists primarily of state income taxes and income taxes in
certain foreign jurisdictions in which we conduct business. We have a full
valuation allowance for deferred tax assets as the realization of the full
amount of our deferred tax asset is uncertain, including NOL, carryforwards, and
tax credits related primarily to research and development. We expect to maintain
this full valuation allowance until realization of the deferred tax assets
becomes more likely than not.



                                       20

--------------------------------------------------------------------------------



                          Three Months Ended June 30,               Change           Six Months Ended June 30,             Change
                          2021                     2020           $        %         2021                 2020           $         %
                                 (in thousands except percentage)                          (in thousands except percentage)

Income tax
(expense) benefit   $            (23 )         $          1     $ (24 )   n/a    $         (63 )       $        (1 )   $ (62 )   6200%



Liquidity and Capital Resources



As of June 30, 2021 and December 31, 2020, we had cash and cash equivalents of
$253.5 million and $73.5 million, respectively. Our principal use of cash is to
fund our operations to support growth.

In June 2020, we completed a follow-on public offering of our shares, resulting
in net proceeds to us of $45.8 million after deducting underwriting discounts
and commissions and deferred offering costs. We used the funds obtained to pay
down all our outstanding debt. In February 2021, we completed an additional
follow-on public offering of our shares, resulting in net proceeds to us of
$181.6 million after deducting underwriting discounts and commissions and
deferred offering costs.

The Company canceled its $50.0 million credit facility with MUFG. We believe
that our existing cash and cash equivalents will be sufficient to meet our cash
needs for at least the next 12 months. Over the longer term, our future capital
requirements will depend on many factors, including our growth rate, the timing
and extent of our sales and marketing and research and development expenditures,
and the continuing market acceptance of our solutions. In the event that we need
to borrow funds or issue additional equity, we cannot provide any assurance that
any such additional financing will be available on terms acceptable to us, if at
all. If we are unable to raise additional capital when we need it, it would harm
our business, results of operations and financial condition.



                                              Six Months Ended June 30,
                                                 2021              2020
                                                    (in thousands)

Net cash provided by operating activities $ 10,390 $ 5,655 Net cash used in investing activities

              (11,965 )        (2,881 )

Net cash provided by financing activities 181,588 36,294 Net increase in cash and cash equivalents $ 180,013 $ 39,068






Operating Activities

In the six months ended June 30, 2021, net cash provided by operating activities
of $10.4 million was primarily due to a net loss of $1.5 million and net
increase in operating assets and liabilities of $5.8 million offset by non-cash
expenses of $17.7 million. Non-cash expenses were mainly related to depreciation
and amortization and stock-based compensation expense. Operating assets and
liabilities increased primarily due to higher accounts payable due to timing of
payments and higher accounts receivables due to timing of shipments partially
offset by an increase in inventories as we managed our inventory levels for
increased demand.

In the six months ended June 30, 2020, net cash provided by operating activities
of $5.7 million was primarily due to a net loss of $10.7 million offset by
non-cash expenses of $9.7 million and a change in operating assets and
liabilities of $6.7 million. Non-cash expenses were mainly related to
depreciation and amortization, stock-based compensation expense, and non-cash
operating lease costs. Operating assets and liabilities increased primarily due
to lower accounts receivables and related party receivables due to timing of
shipments and collections, lower prepaid expenses and other current assets
related to advance payments to suppliers for inventory and higher accrued
expenses and other liabilities due to timing of payments partially offset by an
increase in inventories as we managed our inventory levels.

Investing Activities



Our investing activities consist primarily of capital expenditures for property
and equipment purchases. Our capital expenditures for property and equipment
have primarily been for general business purposes, including machinery and
equipment, leasehold improvements, acquired software, internally developed
software used in production and support of our products, computer equipment used
internally, and production masks to manufacture our products.

In the six months ended June 30, 2021, net cash used in investing activities was
$12.0 million. We paid $11.4 million largely to purchase test and other
manufacturing equipment to support the increase in demand of our products and
other property and equipment for general business purposes.

In the six months ended June 30, 2020, net cash used in investing activities was
approximately $2.9 million and consisted primarily of the purchase of production
masks, internally developed software, and other property and equipment for
general business purposes.



                                       21

--------------------------------------------------------------------------------

Financing Activities

Cash provided by financing activities includes proceeds from borrowings under our credit facilities and proceeds from issuance of shares.



In the six months ended June 30, 2021, net cash provided by financing activities
was $181.6 million, consisting of proceeds from issuance of shares of $190.5
million net of underwriting commissions and discounts of $8.6 million and
deferred offering costs of $0.3 million.

In the six months ended June 30, 2020 net cash provided by financing activities
was $36.3 million, consisting of proceeds from issuance of shares of $45.8
million net of underwriting commissions and discounts of $2.7 million and
deferred offering costs of $0.3 million and borrowings of $35.0 million offset
by repayments of $41.0 million under our short-term revolving line of credit and
$3.5 million payment of tax withholdings paid on behalf of employees for net
share settlement at the time of vesting.

Off-Balance Sheet Arrangements



During the periods presented, we did not have any relationships with
unconsolidated entities or financial partnerships, such as entities often
referred to as structured finance or special purpose entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements
or other contractually narrow or limited purposes.

Critical Accounting Policies and Estimates



Our consolidated financial statements have been prepared in accordance with
GAAP. The preparation of these financial statements and accompanying disclosures
requires us to make estimates and assumptions that affect the reported amounts
of assets, liabilities, revenues and expenses, and related disclosures of
contingent assets and liabilities in the consolidated financial statements and
the accompanying notes. The Securities and Exchange Commission, or SEC, has
defined a company's critical accounting policies as policies that are most
important to the portrayal of a company's financial condition and results of
operations, and which require a company to make its most difficult and
subjective judgments, often as a result of the need to make estimates of matters
that are inherently uncertain. Based on this definition, we have identified our
most critical accounting policies and estimates to be as follows: (1) revenue
recognition; (2) inventory; (3) stock-based compensation; (4) accounting for
income taxes and (5) segment reporting. Although we believe that our estimates,
assumptions, and judgments are reasonable, they are based upon information not
presently available. Actual results may differ significantly from these
estimates if the assumptions, judgments, and conditions upon which they are
based turn out to be inaccurate. Management believes that there have been no
significant changes to the items that we disclosed as our critical accounting
policies and estimates in Management's Discussion and Analysis of Financial
Condition and Results of Operations, in our Annual Report on Form 10-K for the
year ended December 31, 2020 filed with the SEC on February 16, 2021.

© Edgar Online, source Glimpses